Trial intelligence / Profile preview

BEACON

NCT05764733Phase 4Recruiting

Sponsor
Wake Forest University Health Sciences
Start
Jun 2023
Primary completion
Jan 2028
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of alendronate in osteoporosis, sponsored by Wake Forest University Health Sciences. Started Jun 2023; status: recruiting.

02

Drugs

alendronate
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT05764733.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05764733.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call